Proteros

Dedicated to advancing drug discovery, Proteros Biostructures empowers researchers with an array of innovative services. One such offering, covalent fragment screening, enables the identification of highly specific drug candidates, providing a significant advantage in therapeutic development. By leveraging advanced technologies and proprietary methodologies, Proteros ensures clients receive the insights they need to succeed. Their commitment to collaboration and client satisfaction has earned them a loyal customer base across Europe, the US, and Asia. Proteros’ ability to deliver results with precision and efficiency makes them a standout choice for pharmaceutical companies striving for excellence in research and development.